Alta Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-162,051
Closed -$14.5M 91
2018
Q3
$14.5M Sell
162,051
-183,070
-53% -$16.2M 0.8% 40
2018
Q2
$27.4M Sell
345,121
-1,205
-0.3% -$100K 1.69% 26
2018
Q1
$30.9M Buy
346,326
+14,705
+4% +$1.41M 1.92% 25
2017
Q4
$34.6M Sell
331,621
-22,924
-6% -$2.59M 2.18% 23
2017
Q3
$51.7M Sell
354,545
-14,261
-4% -$1.94M 3.34% 8
2017
Q2
$47.9M Sell
368,806
-11,525
-3% -$1.41M 3.24% 10
2017
Q1
$47.3M Buy
380,331
+101,113
+36% +$12.1M 3.17% 9
2016
Q4
$32.3M Sell
279,218
-48,714
-15% -$5.43M 2.32% 19
2016
Q3
$34.3M Buy
327,932
+100,334
+44% +$10.9M 2.13% 24
2016
Q2
$22.4M Buy
227,598
+5,305
+2% +$549K 1.39% 29
2016
Q1
$22.2M Buy
222,293
+14,253
+7% +$1.47M 1.37% 29
2015
Q4
$24.9M Buy
208,040
+9,056
+5% +$1.05M 2.01% 26
2015
Q3
$21.5M Buy
198,984
+184,256
+1,251% +$22.9M 1.83% 31
2015
Q2
$1.7M Buy
14,728
+5,524
+60% +$632K 0.14% 53
2015
Q1
$1.06M Hold
9,204
0.09% 63
2014
Q4
$1.03M Hold
9,204
0.09% 64
2014
Q3
$872K Hold
9,204
0.08% 62
2014
Q2
$790K Buy
9,204
+74
+0.8% +$5.63K 0.07% 65
2014
Q1
$637K Buy
9,130
+5,600
+159% +$443K 0.06% 67
2013
Q4
$298K Hold
3,530
0.03% 71
2013
Q3
$272K Hold
3,530
0.03% 72
2013
Q2
$206K Buy
+3,530
New +$212K 0.03% 76

Other funds holding CELG

Alta Capital Management's CELG Position: Q4 2018 in Review

Alta Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 162,051 shares — an estimated $14.5M sold.

Alta Capital Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $51.7M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Alta Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Alta Capital Management sold 162,051 Celgene Corp shares in Q4 2018, an estimated $14.5M.
  • Alta Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Alta Capital Management's Celgene Corp position peaked at $51.7M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Alta Capital Management's 13F filing for Q4 2018, filed 9 Jan 2019.